Previous
Next

Country/Region

July 20, 2015

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) applauds the results of the Strategic Timing of Antiretroviral Treatment (START) trial, released today at the International AIDS Society Conference (IAS) in Vancouver, showing that immediate treatment is beneficial for the individual regardless of the status of his or her immune system.

October 24, 2013

Since February 2013, an innovative approach, commonly referred to as PMTCT B+ (prevention of mother-to-child transmission, option B+), is being rolled out by Médecins Sans Frontières/Doctors Without Borders (MSF) and the Ministry of Health in the Nhlangano area, in the south of the country. It aims to place 2,000 HIV-positive pregnant women on treatment over the next four years, as soon as possible after their diagnosis. So far, more than 200 women have joined the programme.

September 17, 2013

An innovative approach to preventing mother-to-child transmission of HIV/AIDS is being rolled out by Médecins Sans Frontières (MSF) and the Ministry of Health in the Nhlangano area of southern Swaziland. It will place 2,000 HIV-positive pregnant women on treatment over the next four years, as soon as possible after their diagnosis. So far, more than 200 women have joined the program.

August 08, 2013

“I feel like jumping and dancing and shouting,” said Linda Vilakati. “It has been a long and difficult journey, but I’ve reached the end.”

MSF and Swaziland discuss public health response and finding practical solutions

The Executive Board of UNITAID, the international health financing agency, will meet Dec. 14-15 in Geneva to decide on the future direction of the Patent Pool for AIDS medicines. International medical humanitarian organization Médecins Sans Frontières (MSF) is concerned that a number of pharmaceutical companies are seeking to exclude developing countries categorized as ‘middle-income’ from benefiting from medicines made under licence from the Pool.  If these companies are successful, people living with HIV/AIDS will be made to pay the price.

Lindo, a little girl living in the Kingdom of Swaziland, has had to endure daily injections of the MDR TB treatment drug for the past four months.

At the end of the twentieth century, it was thought that tuberculosis was on its way to being eradicated around the world., But the disease coming back with a vengeance. From Swaziland to Kyrgyzstan MSF teams are fighting its resurgence.

Doctor, psychologist and nurse will travel to affected and isolated areas.

Uninterrupted ARV drug supply crucial to survival

Pages